Differences in the Intrinsic Capacity of Peripheral Blood Mononuclear Cells to Produce Tumor Necrosis Factor Alpha and Beta in Patients with Inflammatory Bowel Disease and Healthy Controls

References

• Shanahan F, Targan SR. Mechanisms of tissue injury in inflammatory bowel disease. Inflammatory bowel disease, R P Mac Dermott, W F Stenson. Elsevier, New York 1992; 77–94
   Google Scholar
• Ruddle NH. Tumor necrosis factor alpha (TNFα) and lymphotoxin (TNFβ). Curr Opin Immunol 1992; 327–32
   PubMed Web of Science ®Google Scholar
• Carswell E A, Old L T, Kassel R L, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666–70
   PubMed Web of Science ®Google Scholar
• Scuderi P, Lam K S, Ryan K J, Petersen E, Sterling K E, Finley PR. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986; 2: 1364–5
   PubMed Web of Science ®Google Scholar
• Balkwill F, Burke F, Talbot D, Tavenier J, Osborne R, Naylor S, et al. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 1987; 2: 1229–32
   PubMed Web of Science ®Google Scholar
• Waage A, Halstensen A, Espewick K. Association between tumour necrosis factor in serum and fatal outcome in meningococcal disease. Lancet 1987; 1: 355–7
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of the host response. Annu Rev lmmunol 1989; 7: 625–9
   PubMed Web of Science ®Google Scholar
• Paul N L, Ruddle NH. Lymphotoxin. Annu Rev lmmunol 1988; 6: 407–10
   PubMed Web of Science ®Google Scholar
• Jacob C O, Fronek Z, Lewis G D, Koo M, Hansen J A, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233–7
   PubMed Web of Science ®Google Scholar
• Toyoda H, Wang S J, Yang H Y, Redford A, Magalong D, Tyan D, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741–8
   PubMed Web of Science ®Google Scholar
• Freidel A C, Betuel H, Gebuhrer L, Farre A, Lambert J. Cellular and serological subtypes of HLA-DR2. Tissue Antigens 1987; 29: 129–40
   PubMedGoogle Scholar
• Sugimura K, Asakura H, Hibi T, Tsuij T, Inoko H. Molecular analysis of genes responsible for the susceptibility to ulcerative colitis within the HLA region. Gastroenterology 1991; 100: A619
   PubMedGoogle Scholar
• Gracia Casanova M, Oudkerk pool M, Penˆa A, Crusius JBA, Fonk J CM, Schieveld S, et al. A subgroup of ulcerative colitis defined with genetic (HLA-DR) and immunological (pANCA) markers. Gastroenterology 1993; 103: A709
   Google Scholar
• Reimund J M, Duclos B, Sapin R, Derlon A, Chamouard P, Baumann R. Systemic tumour necrosis factor in Crohn's disease: relationship to disease activity and Circulating acute phase reactants. Eur J Gastroenterol Hepatol 1992; 4: 919–23
   Web of Science ®Google Scholar
• Maeda M, Watanabe N, Neda H, Yamauchi N, Okamoto T, Sasaki H, et al. Serum tumor necrosis factor activity in inflammatory bowel disease. Immunopharmacol Immunotoxicol 1992; 14: 451–61
   PubMed Web of Science ®Google Scholar
• Murch S H, Lamkin V A, Savage M O, Walker S J, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32: 913–7
   PubMed Web of Science ®Google Scholar
• Mahida Y R, Scott E, Kurlak L, Gallagher A, Hawkey CJ. Interleukin 1 beta, tumour necrosis factor alpha and interleukin 6 synthesis by circulating mononuclear cells isolated from patients with active ulcerative colitis and Crohn's disease. Eur J Gastroenterol Hepatol 1992; 4: 501–7
   Web of Science ®Google Scholar
• Hyams JS, Treem W R, Eddy E, Wyzga N, Moore RE. Tumor necrosis factor alpha is not elevated in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12: 233–6
   PubMed Web of Science ®Google Scholar
• Mazlam M Z, Hodgson H JF. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992; 33: 773–8
   PubMed Web of Science ®Google Scholar
• Nielsen O H, Brynskov J, Bendtzen K. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. Dan Med Bull 1993; 40: 247–9
   PubMedGoogle Scholar
• Isaacs K L, Sartor R B, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587–95
   PubMed Web of Science ®Google Scholar
• Stevens C, Walz G, Singaram C, Lipman M L, Zanker B, Muggia A, et al. Tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992; 37: 818–826
   PubMed Web of Science ®Google Scholar
• Cappello M, Keshav S, Prince C, Jewell D P, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992; 33: 1214–9
   PubMed Web of Science ®Google Scholar
• Braegger C P, Nicholls S, Murch S H, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339: 89–91
   PubMed Web of Science ®Google Scholar
• Murch S H, Braegger C P, Walker-Smith J A, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34: 1705–9
   PubMed Web of Science ®Google Scholar
• Mac Donald T T, Hutchings P, Choy M Y, Murch S, Cooke A. Tumor necrosis factor alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81: 301–5
   PubMed Web of Science ®Google Scholar
• Jones S C, Haidar A, Hagan P. Cytokine production in the mucosa of patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1993; 5: 607–12
   Web of Science ®Google Scholar
• Breese El, Michie C A, Nicholls S W, Murch S H, Williams C B, Domizlo P, et al. Tumor necrosis factor alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994; 106: 1455–66
   PubMed Web of Science ®Google Scholar
• Plevy S E, Targan S R, Deem R L, Toyoda H. Increased mucosal TNF-alpha mRNA levels and numbers of TNF-alpha producing cells are unique to Crohn's disease mucosal inflammation. Gastroenterology 1994; 106: A754
   Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Sand J Gastroenterol 1989; 24: 2–6, Suppl 170
   Web of Science ®Google Scholar
• Sutherland L R, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894–8
   PubMed Web of Science ®Google Scholar
• Best W R, Becktel J M, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index. Gastroenterology 1979; 77: 8434
   Web of Science ®Google Scholar
• Flick D A, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Meth 1984; 68: 167–75
   PubMed Web of Science ®Google Scholar
• Engelberts I, Moller A, Schoen G JM, van der Linden A, Buurman WA. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991; 10: 69–76
   PubMedGoogle Scholar
• Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. Appleton and Lange, San Mateo 1990
   Google Scholar
• Jacob C O, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis. Nature 1988; 331: 356–8
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobsen B, Odum N, et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mono-nuclear cells activated by lipopolysaccharide. Scand J Immunol 1988; 28: 599–606
   PubMed Web of Science ®Google Scholar
• Messer G, Spengler U, Jung M C, Honold G, Blamer K, Pap G R, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of m-beta production. J Exp Med 1991; 173: 209–19
   PubMed Web of Science ®Google Scholar
• Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Back L, et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Stand J Immunol 1991; 33: 3749
   Web of Science ®Google Scholar
• Pociot F, Briant L, Jongeneel C V, Molvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α TNF-Pˆ by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224–31
   PubMed Web of Science ®Google Scholar
• Wilson A G, di Giovine F S, Blakemore A IF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha gene detectable by Ncol restriction Of PCR product. Hum Mol Gen 1992; 1: 353
   PubMedGoogle Scholar
• Wilson A G, De Vries N, Pociot F, di Giovine F S, van der Putte L BA, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557–60
   PubMed Web of Science ®Google Scholar
• Bouma G, Oudkerk Pool M, Crusius J BA, Kolkman J JV, Blomberg B ME, Meuwissen S GM, et al. Haplotype restricted differences in in vitro production Of tumor necrosis factor alpha and lymphotoxin alpha in patients with inflammatory bowel disease and healthy controls [abstract]. Neth J Med 1995; 46: 29A
   Google Scholar
• Penˆa A S, Meuwissen S GM. Clinical subgroups in inflammatory bowel disease. Inflammatory bowel disease: from bench to bedside, S R Targan, F Shanahan. Williams and Wilkins, Baltimore 1994; 272–8
   Google Scholar
• Sachar D B, Andrews H A, Farmer R G, Pallone F, Penˆa A S, Prantera C, et al. Proposed classification of patients subgroups in Crohn's disease. Working team report. Gastroenterol Int 1992; 5: 141–54
   Google Scholar
• Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol 1994; 89: 1957–62
   PubMed Web of Science ®Google Scholar